Investing.com - Benitec Biopharma ADR reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Benitec Biopharma ADR announced earnings per share of $-0.82 on revenue of $1.00K. Analysts polled by Investing.com anticipated EPS of $-0.85 on revenue of $5K.
Benitec Biopharma ADR shares are up 41.67% from the beginning of the year, still down 66.05% from its 52 week high of $12.52 set on June 19, 2020. They are outperforming the Nasdaq which is up 3.81% from the start of the year.
Benitec Biopharma ADR shares gained 0.94% in pre-market trade following the report.
Benitec Biopharma ADR follows other major Healthcare sector earnings this month
Benitec Biopharma ADR's report follows an earnings beat by J&J on April 20, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.34 on revenue of $21.98B.
Pfizer had beat expectations on May 4 with first quarter EPS of $0.93 on revenue of $14.58B, compared to forecast for EPS of $0.7759 on revenue of $13.65B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar